Insulet Corp
Change company Symbol lookup
Select an option...
PODD Insulet Corp
BAC Bank of America Corp
CMSQF Computershare Ltd
UNH UnitedHealth Group Inc
RYAAY Ryanair Holdings PLC
FNGO MicroSectors? FANG+? Index 2X Leveraged ETN
VIVC Vivic Corp
LAD Lithia Motors Inc
SBUX Starbucks Corp
HYLN Hyliion Holdings Corp
Go

Health Care : Health Care Equipment & Supplies | Mid Cap Growth
Company profile

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). The Omnipod System features two discreet devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. The Omnipod System is a discreet two part design, the Omnipod device (Pod) and the PDM that eliminates the need for the external tubing required with conventional pumps. The Pod is a self-adhesive device that the patient fills with insulin and wears directly on the body.

Closing Price
$222.25
Day's Change
-6.47 (-2.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
230.12
Day's Low
221.33
Volume
(Heavy Day)
Volume:
441,006

10-day average volume:
294,599
441,006

Company Profile

Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). The Omnipod System features two discreet devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. The Omnipod System is a discreet two part design, the Omnipod device (Pod) and the PDM that eliminates the need for the external tubing required with conventional pumps. The Pod is a self-adhesive device that the patient fills with insulin and wears directly on the body.

Valuation Ratios

Price/Earnings (TTM)
801.07x
Price/Sales (TTM)
17.67x
Price/Book (MRQ)
25.88x
Price/Cash Flow (TTM)
271.24x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

October 2020
Current Month
2.4M
Previous Month
2.4M
Percent of Float
3.71%
Days to Cover
9.5478 Days

Share Information

PODD is in a share class of common stock
Float
65.4M
Shares Outstanding
65.7M
Institutions Holding Shares
576
103.78%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in thousands.

Company Officers

  • timothy J. ScannellChmn.
  • Shacey PetrovicPres.
  • Wayde D. McMillanCFO
  • Charles AlpucheCOO
  • Bret ChristensenExec.VP

Address

Insider Trading

During the most recent quarter, 62K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.